Hanan A. Tanash

Malmoe, M 21428, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Dissociation of the Hepatic and Pulmonary Axes in Alpha-1 Antitrypsin Deficiency: Independent Trajectories of Organ-Specific Disease.

Dissociation of the Hepatic and Pulmonary Axes in Alpha-1 Antitrypsin Deficiency: Independent Trajectories of Organ-Specific Disease.

Journal: Biomolecules

Published: April 30, 2026

No association between troponin and COPD without cardiovascular influence: findings from a population-based cohort (SCAPIS).

No association between troponin and COPD without cardiovascular influence: findings from a population-based cohort (SCAPIS).

Journal: Thorax

Published: March 27, 2026

From Birth to Midlife-Liver Function, Fibrosis and Mortality in Individuals with Severe Alpha-1-Antitrypsin Deficiency Identified by Neonatal Screening.

From Birth to Midlife-Liver Function, Fibrosis and Mortality in Individuals with Severe Alpha-1-Antitrypsin Deficiency Identified by Neonatal Screening.

Journal: Journal of clinical medicine

Published: February 17, 2026

Genome-wide association study of image-based emphysema scoring in the Swedish CArdioPulmonary bioImage Study (SCAPIS) suggests two new risk loci in smokers.

Genome-wide association study of image-based emphysema scoring in the Swedish CArdioPulmonary bioImage Study (SCAPIS) suggests two new risk loci in smokers.

Journal: Respiratory research

Published: December 29, 2025

Clinical phenotypes in α1-antitrypsin deficiency: a cluster analysis on EARCO data.

Clinical phenotypes in α1-antitrypsin deficiency: a cluster analysis on EARCO data.

Journal: ERJ open research

Published: November 14, 2025

Routine Blood Biomarkers in Patients With the PI*SZ Genotype of Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.

Routine Blood Biomarkers in Patients With the PI*SZ Genotype of Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.

Journal: Archivos de bronconeumologia

Published: November 14, 2025

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden.

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden.

Journal: Scientific reports

Published: September 24, 2025

Isolated, reduced diffusing capacity for carbon monoxide in the population - relations to symptoms, smoking and comorbidities.

Isolated, reduced diffusing capacity for carbon monoxide in the population - relations to symptoms, smoking and comorbidities.

Journal: BMC pulmonary medicine

Published: September 18, 2025

Routine Blood Biomarkers and Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency from the EARCO Registry.

Routine Blood Biomarkers and Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency from the EARCO Registry.

Journal: Respiration; international review of thoracic diseases

Published: July 06, 2025

Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.

Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.

Journal: The European respiratory journal

Published: May 16, 2025

Characteristics of bronchiectasis in patients with different genotypes of severe α1-antitrypsin deficiency from the EARCO registry.

Characteristics of bronchiectasis in patients with different genotypes of severe α1-antitrypsin deficiency from the EARCO registry.

Journal: ERJ open research

Published: April 09, 2025

Clinical characteristics of AATD-related COPD patients vary with age at diagnosis: data from the EARCO international registry.

Clinical characteristics of AATD-related COPD patients vary with age at diagnosis: data from the EARCO international registry.

Journal: BMC pulmonary medicine

Published: March 31, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026